Dr. Indraneel Banerjee, MD

Dr. Banerjee practices at Penn Highlands DuBois in Du Bois, Pennsylvania, part of Penn Highlands Healthcare.

Dr. Banerjee's NPI, 1386135457, was assigned on May 24, 2018. Dr. Banerjee holds Pennsylvania license MD479671.

Dr. Banerjee's primary practice is Penn Highlands DuBois, at 100 Hospital Avenue, Du Bois, PA 15801 in Clearfield County. The practice phone is (814) 371-2200.

Dr. Banerjee's primary practice is Penn Highlands DuBois in Du Bois, Pennsylvania, part of Penn Highlands Healthcare. Dr. Banerjee is also affiliated with UF Health Jacksonville. The medical group on file is Penn Highlands DuBois. Dmand AI also links Dr. Banerjee to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Banerjee practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Banerjee's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Banerjee is licensed in Pennsylvania.

CMS data shows 479 Medicare services from Dr. Banerjee across 9 procedure codes in 2024, for 325 Medicare patients. Medicare paid $37,524 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 325 Medicare patients who saw Dr. Banerjee in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Banerjee's median patient age at 73, with 23% women.

In 2024, Dr. Banerjee wrote 868 Medicare Part D claims for 290 patients. 87% of them were for generic drugs. CMS names the drug for 788 of them, across 16 drugs with 11 or more claims each, at $165,210 in total drug cost. In 2023, CMS named 379 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Banerjee for performance year 2024, reported as part of a group. Dr. Banerjee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Banerjee as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 139 papers to Dr. Banerjee, published from 2010 to 2025. 2020 was the busiest year, with 14. The most frequent topics are Congenital Hyperinsulinism, Blood Glucose and Hypoglycemia. Dr. Banerjee has published most often in Front Endocrinol (Lausanne). Dr. Banerjee's most frequent co-authors are Paul S. Thornton, MD, Abhishek Bhat, MD and Jonathan Katz, MD.

CMS Open Payments shows 131 general payments to Dr. Banerjee from 23 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 66% of the total. Boston Scientific Corporation paid the most, $2,026.